Danyang Dajiang Chemical Factory | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (516) 8878-8888 8878-1988 | |||
![]() |
dajiang@dajiang-chem.com | |||
Chemical manufacturer | ||||
chemBlink standard supplier since 2007 | ||||
Hefei TNJ Chemical Industry Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (551) 6541-8684 | |||
![]() |
sales@tnjchem.com | |||
Chemical manufacturer since 2001 | ||||
chemBlink standard supplier since 2010 | ||||
Wilshire Technologies, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (609) 683-1117 | |||
![]() |
Wilshire-info@evonik.com | |||
Chemical manufacturer since 1997 | ||||
chemBlink standard supplier since 2010 | ||||
BOC Sciences | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
Chemical manufacturer | ||||
chemBlink standard supplier since 2010 | ||||
Medilink Pharmachem | India | Inquire | ||
---|---|---|---|---|
![]() |
+91 (79) 3007-0133 | |||
![]() |
exports@medilinkpharma.com | |||
Chemical distributor since 1996 | ||||
chemBlink standard supplier since 2014 | ||||
Leap Chem Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (852) 3060-6658 | |||
![]() |
market19@leapchem.com | |||
![]() |
QQ chat | |||
Chemical manufacturer since 2006 | ||||
chemBlink standard supplier since 2015 | ||||
Hangzhou Chiral Medicine Chemicals Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (571) 8262-3231 8263-8910 8263-8927 | |||
![]() |
chiral@xs.hz.zj.cn | |||
Chemical manufacturer since 1998 | ||||
Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (831) 457-3800 | |||
![]() |
scbt@scbt.com | |||
Chemical manufacturer | ||||
Classification | API >> Circulatory system medication >> Antihypertensive drug |
---|---|
Name | Labetalol hydrochloride |
Synonyms | 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride |
Molecular Structure | ![]() |
Molecular Formula | C19H24N2O3.HCl;C19H25ClN2O3 |
Molecular Weight | 364.87 |
CAS Registry Number | 32780-64-6 |
EC Number | 251-211-1 |
Hazard Symbols |
![]() | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Risk Codes | R22 Details | ||||||||||||||||||||||||||||||||||||||||
Safety Description | S36 Details | ||||||||||||||||||||||||||||||||||||||||
Hazard Classification | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
SDS | Available | ||||||||||||||||||||||||||||||||||||||||
Market Analysis Reports |
List of Reports Available for Labetalol hydrochloride |